Univercells launches cell & gene therapy contract development and manufacturing organization (CDMO) Exothera with GMP capabilities in 15,000m² site in Jumet

March 19th 2020


Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral vectors. The company has been created to help alleviate the two most critical challenges manufacturers face in bringing these vital therapies to market: a structural lack of capacity and scarcity of bioprocessing expertise.
Exothera is uniquely positioned to create bespoke bioproduction support programs for manufacturers to achieve successful market entry.  Please discover the press release here.